Close
Home
Exclusives
Recapitalization
Financial Analysis
Corporate Stories
Interviews
Investigations
Metrics
Nairalytics
Economy
Business News
Budget
Public Debt
Tax
Markets
Currencies
Cryptos
Commodities
Equities
Fixed Income
Funds Management
Securities
Sectors
Agriculture
Aviation
Company News
Consumer Goods
Corporate Updates
Corporate deals
Corporate Press Releases
Energy
Entertainment
Financial Services
Health
Hospitality & Travel
Manufacturing
Real Estate and Construction
Renewables & Sustainability
Tech News
Financial Literacy
Career tips
Personal Finance
Lifestyle
Billionaire Watch
Profiles
Opinions
Blurb
Market Views
Op-Eds
Research Analysis
Search
Tag
OXBRYTA
Health
Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide
Pfizer has announced the global withdrawal of its sickle cell disease treatment, Oxbryta (voxelotor), which was priced at approximately $125,000 per year.
RELATED TAGS
# News Review
# On the Money
# CBN
# Featured
# Business News
# Nigeria News
# Bitcoin
# Covid-19
